April 15, 2026
1 min read

New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data MedNews

WEDNESDAY, April 15, 2026 The U.S. Food and Drug Administration (FDA) has told Eli Lilly to study possible heart, liver and other risks tied to its new obesity

Leave a Reply

Your email address will not be published.

Previous Story

Trump DOJ report says Biden administration treated anti-abortion protestors unfairly

Next Story

STAT+: FDA panel will meet to discuss allowing broader access to certain peptides

Previous Story

Trump DOJ report says Biden administration treated anti-abortion protestors unfairly

Next Story

STAT+: FDA panel will meet to discuss allowing broader access to certain peptides

Latest from Blog

SunStar Davao

Davao City Councilor Rachel Zozobrado said that she is still refining two proposed health-oriented food ordinances aimed at promoting healthier food consumption and improving nutritional transparency… Post Views: 1
Go toTop